{"title":"Is a history of cesarean section a predictive factor for the failure of medical management in spontaneous abortion?","authors":"Ravit Pertez-Machluf, Maya Youran Kimhi, Rotem Yedidia Moser, Nissim Arbib, Yair Daykan, Omer Weitzner, Ron Schonman, Zvi Klein, Yael Yagur","doi":"10.1007/s00404-026-08504-1","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>This study aims to evaluate the risk factors for failure of medical treatment for first-trimester spontaneous abortion and the specific role of prior cesarean delivery (CD).</p><h3>Methods</h3><p>This retrospective cohort study analyzed data from patients who underwent medical management of first-trimester spontaneous abortion using mifepristone and misoprostol at a tertiary medical center between 2019 and 2022. Data collected included demographic, clinical, and sonographic parameters, with comparisons made between patients with successful and unsuccessful treatment outcomes. Univariable and multivariable logistic regression analyses were conducted.</p><h3>Results</h3><p>Among the 716 patients included in the study, treatment failure was observed in 29.5%. In multivariable analysis, prior CD was independently associated with an increased risk of treatment failure (aOR 1.97; 95%CI 1.25–3.12; <i>p</i> = 0.004). Additionally, advanced gestational age was also associated with an increased likelihood of failure (aOR 1.02 per day; 95%CI 1.00–1.03; <i>p </i>= 0.009). In subgroup analyses, patients with prior CD had higher failure rates compared with those without prior CD (43.2% vs 27.4%, <i>p</i> = 0.002). Among patients without prior CD, gestational age > 70 days was associated with higher failure rates compared with ≤ 70 days (35.2% vs 24.3%, <i>p </i>= 0.006). In this subgroup (no prior CD and gestational age ≤ 70 days), the presence of bleeding during treatment was associated with lower failure rates (12.5% vs 25.6%, <i>p</i> = 0.001).</p><h3>Conclusion</h3><p>Prior cesarean delivery was independently associated with an increased risk of treatment failure following medical management of first-trimester spontaneous abortion. Advanced gestational age was also associated with increased failure rates. Further studies are needed to refine treatment protocols and explore approaches for patients with prior CD.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13572325/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Gynecology and Obstetrics","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00404-026-08504-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
This study aims to evaluate the risk factors for failure of medical treatment for first-trimester spontaneous abortion and the specific role of prior cesarean delivery (CD).
Methods
This retrospective cohort study analyzed data from patients who underwent medical management of first-trimester spontaneous abortion using mifepristone and misoprostol at a tertiary medical center between 2019 and 2022. Data collected included demographic, clinical, and sonographic parameters, with comparisons made between patients with successful and unsuccessful treatment outcomes. Univariable and multivariable logistic regression analyses were conducted.
Results
Among the 716 patients included in the study, treatment failure was observed in 29.5%. In multivariable analysis, prior CD was independently associated with an increased risk of treatment failure (aOR 1.97; 95%CI 1.25–3.12; p = 0.004). Additionally, advanced gestational age was also associated with an increased likelihood of failure (aOR 1.02 per day; 95%CI 1.00–1.03; p = 0.009). In subgroup analyses, patients with prior CD had higher failure rates compared with those without prior CD (43.2% vs 27.4%, p = 0.002). Among patients without prior CD, gestational age > 70 days was associated with higher failure rates compared with ≤ 70 days (35.2% vs 24.3%, p = 0.006). In this subgroup (no prior CD and gestational age ≤ 70 days), the presence of bleeding during treatment was associated with lower failure rates (12.5% vs 25.6%, p = 0.001).
Conclusion
Prior cesarean delivery was independently associated with an increased risk of treatment failure following medical management of first-trimester spontaneous abortion. Advanced gestational age was also associated with increased failure rates. Further studies are needed to refine treatment protocols and explore approaches for patients with prior CD.
目的:本研究旨在评估早期自然流产药物治疗失败的危险因素及既往剖宫产(CD)的具体作用。方法:本回顾性队列研究分析了2019年至2022年在三级医疗中心接受米非司酮和米索前列醇治疗的妊娠早期自然流产患者的数据。收集的数据包括人口统计学、临床和超声参数,并对治疗成功和不成功的患者进行比较。进行单变量和多变量logistic回归分析。结果:纳入研究的716例患者中,29.5%的患者治疗失败。在多变量分析中,既往CD与治疗失败风险增加独立相关(aOR 1.97; 95%CI 1.25-3.12; p = 0.004)。此外,高龄妊娠也与流产的可能性增加有关(aOR为1.02 /天;95%CI为1.00-1.03;p = 0.009)。在亚组分析中,有既往CD的患者比没有既往CD的患者失败率更高(43.2% vs 27.4%, p = 0.002)。在没有既往CD的患者中,与≤70天的患者相比,胎龄≤70天的患者失败率更高(35.2% vs 24.3%, p = 0.006)。在该亚组中(无既往CD且胎龄≤70天),治疗期间出血的存在与较低的失败率相关(12.5% vs 25.6%, p = 0.001)。结论:有过剖宫产经历与妊娠早期自然流产药物治疗后治疗失败的风险增加独立相关。孕龄过长也与失败率增加有关。需要进一步的研究来完善治疗方案并探索治疗既往CD患者的方法。
期刊介绍:
Founded in 1870 as "Archiv für Gynaekologie", Archives of Gynecology and Obstetrics has a long and outstanding tradition. Since 1922 the journal has been the Organ of the Deutsche Gesellschaft für Gynäkologie und Geburtshilfe. "The Archives of Gynecology and Obstetrics" is circulated in over 40 countries world wide and is indexed in "PubMed/Medline" and "Science Citation Index Expanded/Journal Citation Report".
The journal publishes invited and submitted reviews; peer-reviewed original articles about clinical topics and basic research as well as news and views and guidelines and position statements from all sub-specialties in gynecology and obstetrics.